Christopher Contag, the inaugural James and Kathleen Cornelius Endowed Chair, was recruited to MSU from Stanford to lead the new Institute for Quantitative Health Science and Engineering.
His research at MSU will change the way the world thinks about biomedicine through developing new technologies and approaches for precision health and medicine to change how healthcare can be delivered to patients.
Prior to joining MSU, he held many roles at Stanford, including associate chief of Neonatal and Developmental Medicine, director of Stanford’s Center for Innovation in In Vivo Imaging, and co-director of the Molecular Imaging Program.
Dr. Contag is a fellow and past president of the World Molecular Imaging Society. His research has been published in a number of journals including Science, Nature Medicine, Nature Biotechnology, Proceedings of the National Academy of Sciences, and PloS.
He is a founding member and past president of the Society for Molecular Imaging (SMI), and recipient of the Achievement Award from the SMI and the Britton Chance Award from SPIE for his fundamental contributions to optics.
Dr. Contag graduated from the University of Minnesota with both an undergraduate degree in biology and a Ph.D. in microbiology.